TGFB1 and non-small cell lung carcinoma: Therefore, our study aimed to investigate the presence and function of pSMAD2L, as NSCLC is still capable of proliferating despite an activated TGFβ signalling cascade, which requires processes to overcome the anti-proliferative effects of active TGFβ signalling.